Lsbcal
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
I bought Merck (MRK) based on the approval of it's antiviral drug in the UK. It pays a 2.9% dividend which is nice. For me, this is a fairly low risk short term speculation in a non-taxable account.
Complete article: https://www.cnbc.com/2021/11/04/merck-oral-covid-pill-approved-by-uk-in-world-first.html
Value Line gives it the highest safety rating of 1, and 2 for timeliness. Before the approval Morningstar had a fair value of 94. Other services such as Schwab, Argus are positive on MRK. I don't expect it to be another Moderna but maybe a decent return as opposed to bonds with a decent helping of risk too.
Based on the clinical trial data, the oral pill is most effective when taken during the early stages of infection. As such, the British regulator recommended its use as soon as possible following a positive Covid test and within five days of the onset of symptoms.
The antiviral pill has been authorized for use in people who have mild to moderate Covid and at least one risk factor for developing severe illness, such as obesity, diabetes mellitus, or heart disease and anyone over the age of 60.
Complete article: https://www.cnbc.com/2021/11/04/merck-oral-covid-pill-approved-by-uk-in-world-first.html
Value Line gives it the highest safety rating of 1, and 2 for timeliness. Before the approval Morningstar had a fair value of 94. Other services such as Schwab, Argus are positive on MRK. I don't expect it to be another Moderna but maybe a decent return as opposed to bonds with a decent helping of risk too.
Last edited: